Skip to main content

Headlines

Omicron is mutating in giant leaps, challenging vaccine efficacy and complicating treatment. But this fall, broad spectrum bivalent vaccines may help mitigate the seemingly never ending spread of COVID-19.

Faculty

George Dimopoulos
Professor
Molecular Microbiology and Immunology

George Dimopoulos, PhD, MBA, studies vector-borne diseases and how mosquitoes can be rendered incapable of transmitting human pathogens.

Andrew Pekosz
Professor
Molecular Microbiology and Immunology

Andy Pekosz, PhD, investigates the replication and disease potential of respiratory viruses including influenza, SARS-CoV-2 and other emerging viruses.